PTK2 and ovarian cancer: Shibata et al. [42] have shown that stimulated ovarian cancer cells with fibronectin activated MMP-9 secretion, while both antisense oligonucleotide to FAK and dominant-negative mutation of Ras abolished this phenomenon.